Close
American Drug Delivery & Formulation Summit
Xylem

News

Scipher Medicine and Leading Medical Researchers in Network and Data Science Compress Time to Identify Covid-19 Treatments from Years to Months

Scipher Medicine, a precision immunology company matching patients with the most effective therapy, in collaboration with Northeastern University; Brigham and Womenโ€™s Hospital, Harvard Medical School, and Boston Universityโ€™s National Emerging Infectious Diseases Laboratories (NEIDL), today announced they identified novel...

AARDEX Group and AdhereTech Partnership Boosts Medication Adherence with Software, Data Analytics and Smart Pill Bottle

Belgium-based AARDEX Group, the world leader in medication adherence solutions, announced a strategic partnership with AdhereTech, an innovative company that improves the patient experience with real-time technology and Smart devices for optimal medication benefits. The collaboration will link AARDEXโ€™s...

Genezen Strengthens Leadership with New Board Appointments

Following major growth, Genezen Laboratories Inc, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has announced the appointment of three board members: Iain Baird, Diana Caldwell and Tedd Green. The expansion of the team comes as Genezen...

Singapore-UK Team To Develop a Novel Device to Reduce Chemotherapy Side-Effects

A team of clinicians and scientists from the National University Cancer Institute, Singapore (NCIS) at the National University Hospital (NUH) and the N.1 Institute for Health at the National University of Singapore (NUS) has partnered Paxman Coolers Ltd (UK)...

Ashfield Advisory takes strategic step forward with two new additions to senior leadership team

Ashfield Advisory, an ecosystem of healthcare advisory and consulting businesses, part of UDG Healthcare plc., has announced two senior leadership appointments. Mary-Kate McGarry joins in the new position of Vice President of Strategy and Emer Jameson, steps into the role...

Vibalogics invests an additional $50 million to further expand cGMP manufacturing capacity for viral vectors

Vibalogics, a global contract development and manufacturing organization (CDMO), has today announced that it has initiated the first stage of a planned $50 million dollar investment at its Cuxhaven, Germany facility, expanding early-to-late phase clinical virotherapy manufacturing capacity. The investment...

MaxiVision Eye Hospitals launches Mucormycosis (Black Fungus) Early Detection Center

MaxiVision Eye Hospitals group, the pioneers in the industry of eye care medical services have launched โ€œMucormycosis (Black Fungus) Early Detection Centerโ€ at its Somajiguda Branch in Hyderabad to identify the virulent fungal infection in its initial stage preventing...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป